How delays derailed Covid-19 vaccination in Africa

As we inch closer to WHO’s deadline for vaccinating most of the world’s population, assessing the progress in many African countries requires nuance, writes Andrew Hillman.

IN DEPTH

CAR-Ts in China: the dawn of an immunotherapy superpower

Comment

It will take years for AI use to peak in drug discovery and development

Go to article: Home | How delays derailed Covid-19 vaccination in AfricaGo to article: In this issueGo to article: ContentsGo to article: CSafe GlobalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: SHL MedicalGo to article: Stormy StudioGo to article: CommentGo to article: It will take years for AI use to peak in drug discovery and development processGo to article: Bear market hits Europe’s innovator drug venture financing, losing pace with USGo to article: Longevity technology and its futureGo to article: Potential impact on women’s healthcare post-Roe versus WadeGo to article: Dupixent approval brings first biologic to youngest atopic dermatitis patientsGo to article: BioLife SolutionsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: In DepthGo to article: How delays derailed Covid-19 vaccination in AfricaGo to article: Is pharma doing enough to tackle the opioid epidemic?Go to article: Decoding the Covid-19 connection with diabetesGo to article: CAR-Ts in China: the dawn of an immunotherapy superpowerGo to article: Drawing on data to make oncology trials diverseGo to article: NiproGo to article: BEA TechnologiesGo to article: In DataGo to article: The pharmaceutical industry found it harder to fill cybersecurity vacancies in Q1 2022Go to article: Debt offerings decreased significantly in the pharmaceutical industry in H2 2021Go to article: Partnerships decreased in the pharmaceutical industry in H2 2021Go to article: Europe is seeing a hiring boom in pharmaceutical industry big data rolesGo to article: EventsGo to article: Next issue